Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting the p53-MDM2 pathway for neuroblastoma therapy: Rays of hope
Atif Zafar, Wei Wang, Gang Liu, et al.
Cancer Letters (2020) Vol. 496, pp. 16-29
Open Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

Exosomal circular RNAs: A chief culprit in cancer chemotherapy resistance
Xu Guo, Congying Gao, Dong‐Hua Yang, et al.
Drug Resistance Updates (2023) Vol. 67, pp. 100937-100937
Closed Access | Times Cited: 92
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
Wei Wang, Najah Albadari, Yi Du, et al.
Pharmacological Reviews (2024) Vol. 76, Iss. 3, pp. 414-453
Open Access | Times Cited: 26
Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches
Fangfang Liu, Jingyu Chen, Kai Li, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 19
Emerging Trends in Neuroblastoma Diagnosis, Therapeutics, and Research
Rishabh Sharma, Jaya Yadav, Sajad Ahmad Bhat, et al.
Molecular Neurobiology (2025)
Closed Access | Times Cited: 1
PROTAC degraders with ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective
Xin Han, Wenyi Wei, Yi Sun
Acta Materia Medica (2022) Vol. 1, Iss. 2
Open Access | Times Cited: 45
Radiotherapy modulates tumor cell fate decisions: a review
Hao Chen, Zhongyu Han, Qian Luo, et al.
Radiation Oncology (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 40
Small molecules targeting protein–protein interactions for cancer therapy
Defa Wu, Yang Li, Lang Zheng, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 10, pp. 4060-4088
Open Access | Times Cited: 31
Untangling the Role of MYC in Sarcomas and Its Potential as a Promising Therapeutic Target
Fabio Sias, Stefano Zoroddu, Rossana Migheli, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1973-1973
Open Access
USP2 reversed cisplatin resistance through p53-mediated ferroptosis in NSCLC
Yanmei Gong, Ruichao Li, Rui Zhang, et al.
BMC Medical Genomics (2025) Vol. 18, Iss. 1
Open Access
MYCN Impact on High-Risk Neuroblastoma: From Diagnosis and Prognosis to Targeted Treatment
Damiano Bartolucci, Luca Montemurro, Salvatore Raieli, et al.
Cancers (2022) Vol. 14, Iss. 18, pp. 4421-4421
Open Access | Times Cited: 30
Identification of a novel heterogeneous nuclear ribonucleoprotein A2B1 (hnRNPA2B1) ligand that disrupts HnRNPA2B1/nucleic acid interactions to inhibit the MDMX-p53 axis in gastric cancer
Lei Hu, Shuqi Liu, Hongying Yao, et al.
Pharmacological Research (2023) Vol. 189, pp. 106696-106696
Open Access | Times Cited: 15
Mechanisms and molecular characterization of relapsed/refractory neuroblastomas
Chong Chen, Zixuan Wei
Frontiers in Oncology (2025) Vol. 15
Open Access
Amyloid aggregates induced by the p53-R280T mutation lead to loss of p53 function in nasopharyngeal carcinoma
Jingzhi Li, Ming Guo, Lin Chen, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
A comprehensive study of p53 protein
Manisha R Patil, Anand Bihari
Journal of Cellular Biochemistry (2022) Vol. 123, Iss. 12, pp. 1891-1937
Closed Access | Times Cited: 21
MiRNA Differences Related to Treatment-Resistant Schizophrenia
Daniel Pérez-Rodríguez, Maria Aránzazu Penedo, Tania Rivera-Baltanás, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 1891-1891
Open Access | Times Cited: 11
A Focus on Regulatory Networks Linking MicroRNAs, Transcription Factors and Target Genes in Neuroblastoma
Patrizia Perri, Mirco Ponzoni, Maria Valeria Corrias, et al.
Cancers (2021) Vol. 13, Iss. 21, pp. 5528-5528
Open Access | Times Cited: 25
Precise pancreatic cancer therapy through targeted degradation of mutant p53 protein by cerium oxide nanoparticles
Hao Zhang, Wang Zhang, Bochuan Hu, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 9
Structure-based discovery of novel α-aminoketone derivatives as dual p53-MDM2/MDMX inhibitors for the treatment of cancer
Huijuan Luo, Dongjuan Si, Xin-jie Sun, et al.
European Journal of Medicinal Chemistry (2023) Vol. 252, pp. 115282-115282
Closed Access | Times Cited: 8
p53-regulated lncRNAs in cancers: from proliferation and metastasis to therapy
Kaixin Yang, Yinan Xiao, Linghui Zhong, et al.
Cancer Gene Therapy (2023) Vol. 30, Iss. 11, pp. 1456-1470
Closed Access | Times Cited: 7
CHEK2 knockout is a therapeutic target for TP53-mutated hepatocellular carcinoma
Yu‐Yan Chen, Zhengyi Zhu, Xing-Yu Wu, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 2
An anti-GD2 aptamer-based bifunctional spherical nucleic acid nanoplatform for synergistic therapy targeting MDM2 for retinoblastoma
Shijing Wang, Yan Zhao, Fei Yao, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116437-116437
Open Access | Times Cited: 2
Storax Attenuates Cardiac Fibrosis following Acute Myocardial Infarction in Rats via Suppression of AT1R–Ankrd1–P53 Signaling Pathway
Zhuo Xu, Danni Lu, Jianmei Yuan, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13161-13161
Open Access | Times Cited: 13
Co-Delivery of p53 Restored and E7 Targeted Nucleic Acids by Poly (Beta-Amino Ester) Complex Nanoparticles for the Treatment of HPV Related Cervical Lesions
Jinfeng Xiong, Guannan Li, Xinyu Mei, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 11
TP53 and TP53-associated genes are correlated with the prognosis of paediatric neuroblastoma
Haiwei Wang, Xinrui Wang, Liangpu Xu, et al.
BMC Genomic Data (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 11
Resveratrol triggers the ER stress-mediated intrinsic apoptosis of neuroblastoma cells coupled with suppression of Rho-dependent migration and consequently prolongs mouse survival
Ding‐Ping Sun, Jui‐Tai Chen, Shun‐Tai Yang, et al.
Chemico-Biological Interactions (2023) Vol. 382, pp. 110645-110645
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top